Essential Retail Pharmacies Under the Consolidated Appropriations Act of 2026

This cross-sectional study investigates the distribution and characteristics of essential retail pharmacies (ERPs) designated by the Consolidated Appropriations Act of 2026 and considers policy amendments to ensure patient access to ERPs is protected.

Corresponding Author: Dima M. Qato, PharmD, MPH, PhD, Program on Medicines and Public Health, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, 1540 Alcazar St, Los Angeles, CA 90089 (qato@usc.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.